Search
for
Sort by
Research 481–510 of 1000+
- Clinical development and management of adverse events associated with FGFR inhibitors
- Cutaneous Reactions to Chemotherapeutic Agents
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda®)
- Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients.
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs
- Non-Rash Skin Toxicities Associated with Novel Targeted Therapies
- Innovative Uses for Zinc in Dermatology
- Finasteride adverse effects in subjects with androgenic alopecia: A possible therapeutic approach according to the lateralization process of the brain
- Dermoscopic evaluation of skin in healthy cats
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Skin toxicity of anti‐cancer therapy
- The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma
- Prophylaxis and Management of Skin Toxicities
- Clinical Management of Cutaneous Adverse Events in Patients on Chemotherapy: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Deferasirox, an oral iron chelator, prevents hepatocarcinogenesis and adverse effects of sorafenib
- Patient‐Level Adverse Event Patterns in a Single‐Institution Study of the Multi‐Kinase Inhibitor Sorafenib
- The risk of dermatological toxicities of combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma patients: a systematic review and meta-analysis
- Impact of the COVID‐19 pandemic on inpatient dermatology: a multicentre study from Hubei, China
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- The O'Connor Tweezer Dexterity Test as a Screening Tool for Hiring Surgical Hair Restoration Assistants
- Targeted Therapy– and Chemotherapy-Associated Skin Toxicities: Systematic Review and Meta-Analysis
- Norman Orentreich, The Father of Hair Transplantation
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Footprints of the EADV: a meeting report from the 17th Congress of the European Academy of Dermatology and Venereology
- Diagnosis and treatments of hirsutism: where are we?